Linezolid

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

71 API Suppliers, 30 USDMF, 5 JDMF, 20 EU WC, 7 KDMF, 19 NDC API, 47 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

6 Drugs in Development

6 Drugs in Development

INTERMEDIATES

21 Intermediates Suppliers

21 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

186 FDF Dossiers, 36 FDA Orange Book, 62 Europe, 7 Canada, 21 South Africa, 60 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 600MG, SOLUTION;INTRAVENOUS - 200MG/100ML (2MG/ML), SOLUTION;INTRAVENOUS - 400MG/200ML (2MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;INTRAVENOUS - 600MG/300ML (2MG/ML)

RELATED EXCIPIENT COMPANIES

1 Minakem, 4 Rochem International Inc, 17 SPI Pharma, 2 Seqens, 6 DKSH, 2 Jai Radhe Sales, 1 Pharm-RX Chemical, 9 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 14 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 ACG Worldwide, 9 Actylis, 1 Aeon Procare, 3 Alcedo Pharmachem, 12 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 30 BASF, 2 Clariant, 12 Corel Pharma Chem, 6 DFE Pharma, 1 Doshion Polyscience, 1 Finar, 8 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 5 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 31 Kerry, 5 Kima Chemical, 6 Lonza Capsugel, 19 Microlex e.U, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 4 Novo Excipients, 5 Pharmatrans-Sanaq, 8 Pluviaendo, 5 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 25 Roquette, 7 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 4 The Dow Chemical Company, 3 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

99 Fillers, Diluents & Binders, 53 Coating Systems & Additives, 51 Direct Compression, 49 Disintegrants & Superdisintegrants, 36 Thickeners and Stabilizers, 34 Granulation, 34 Controlled & Modified Release, 26 Taste Masking, 23 Lubricants & Glidants, 20 Solubilizers, 20 Chewable & Orodispersible Aids, 19 Film Formers & Plasticizers, 18 Co-Processed Excipients, 17 Parenteral, 13 Topical, 9 Rheology Modifiers, 6 API Stability Enhancers, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Coloring Agents, 4 Emulsifying Agents, 2 Surfactant & Foaming Agents

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 44 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 40 Finished Drug Prices, 8 Annual Reports

MARKET PLACE

43 APIs, 20 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 Health Canada Patents

4 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 USP, 15 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

Linezolid

Filters

FILTER :

filter Company Reset all filters

1 All

01 1Qianhao Chemical (Hebei) Co., Ltd

filter Capability Reset all filters

filter Country Reset all filters

01

Qianhao Chemical (Hebei) Co., Ltd

HYDROXYPROPYL METHYL CELLULOSE

The Pharmacy Technology

Not Confirmed

Looking for Pharmaceutical Excipients offered by Qianhao Chemical (Hebei) Co., Ltd? Find Hydroxypropyl Methylcellulose based excipient solutions to address drug delivery challenges on PharmaCompass.

Linezolid

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

71 API Suppliers

30 USDMF

5 JDMF

20 EU WC

7 KDMF

19 NDC API

47 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

6 Drugs in Development

INTERMEDIATES

21 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

186 FDF Dossiers

36 FDA Orange Book

62 Europe

7 Canada

21 South Africa

60 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 600MG

SOLUTION;INTRAVENOUS - 200MG/100ML (2MG/ML)

SOLUTION;INTRAVENOUS - 400MG/200ML (2MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;INTRAVENOUS - 600MG/300ML (2MG/ML)

RELATED EXCIPIENT COMPANIES

1 Minakem

4 Rochem International Inc

17 SPI Pharma

2 Seqens

6 DKSH

2 Jai Radhe Sales

1 Pharm-RX Chemical

9 Boai NKY Pharmaceuticals Ltd

1 Chynops Pharma

14 Gangwal Healthcare

3 Nanjing Well Pharmaceutical

2 Pfanstiehl

1 ACG Worldwide

9 Actylis

1 Aeon Procare

3 Alcedo Pharmachem

12 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

30 BASF

2 Clariant

12 Corel Pharma Chem

6 DFE Pharma

1 Doshion Polyscience

1 Finar

8 Gangwal Chemicals

1 Huzhou Sunflower Pharmaceutical

5 Ideal Cures Pvt Ltd

5 Ingredion Pharma Solutions

31 Kerry

5 Kima Chemical

6 Lonza Capsugel

19 Microlex e.U

1 NEWEDGE Overseas

2 Nomisma Healthcare

4 Novo Excipients

5 Pharmatrans-Sanaq

8 Pluviaendo

5 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

25 Roquette

7 Seppic

7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

12 Sigachi Industries

4 The Dow Chemical Company

3 Ulanqab Kema New Material

1 Valens Pharmachem

TABLET;ORAL - 400MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SOLUTION;INTRAVENOUS - 400MG/200ML (2MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons